A motor cortex excitability and gait analysis on Parkinsonian patients

Movement Disorders

Volumn 25, Issue 16, 2010, Pages 2747-2755

  Vacherot, François ^a,b   Attarian, Shahram ^b   Vaugoyeau, Marianne ^a   Azulay, Jean Philippe ^a,b  

^a CNRS   (France)

^b TIMONE HOSPITAL   (France)

Author keywords

Gait analysis; Parkinson's disease; Stride length; Transcranial magnetic stimulation

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA;

ADULT; AGED; AMPLITUDE MODULATION; ARTICLE; CADENCE; CLINICAL ARTICLE; CONDITIONED REFLEX; CONTROLLED STUDY; EVOKED MUSCLE RESPONSE; FEMALE; GAIT; HUMAN; KINEMATICS; LOCOMOTION; MALE; MOTOR CORTEX; NERVE EXCITABILITY; NERVOUS SYSTEM PARAMETERS; PARKINSON DISEASE; PRIORITY JOURNAL; STRIDE DURATION; STRIDE LENGTH; TRANSCRANIAL MAGNETIC STIMULATION; WALKING SPEED;

AGED; ELECTRIC STIMULATION; ELECTROMYOGRAPHY; EVOKED POTENTIALS, MOTOR; FEMALE; GAIT; HUMANS; MALE; MIDDLE AGED; MOTOR CORTEX; MUSCLE, SKELETAL; PARKINSON DISEASE; STATISTICS, NONPARAMETRIC; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 78650207697     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23378     Document Type: Article

References (62)

1. Valls-Sole J, Valldeoriola F. Neurophysiological correlate of clinical signs in Parkinson's disease. Clin Neurophysiol 2002; 113: 792-805.
2. Kujirai T, Caramia MD, Rothwell JC, et al. Corticocortical inhibition in human motor cortex. J Physiol 1993; 471: 501-519.
3. Valls-Sole J, Pascual-Leone A, Brasil-Neto JP, Cammarota A, McShane L, Hallett M. Abnormal facilitation of the response to transcranial magnetic stimulation in patients with Parkinson's disease. Neurology 1994; 44: 735-741.
4. Priori A, Berardelli A, Inghilleri M, Accornero N, Manfredi M. Motor cortical inhibition and the dopaminergic system. Pharmacological changes in the silent period after transcranial brain stimulation in normal subjects, patients with Parkinson's disease and drug-induced parkinsonism. Brain 1994; 117(Pt 2): 317-323.
5. Bares M, Kanovsky P, Klajblova H, Rektor I. Intracortical inhibition and facilitation are impaired in patients with early Parkinson's disease: a paired TMS study. Eur J Neurol 2003; 10: 385-389.
6. Hallett M, Khoshbin S. A physiological mechanism of bradykinesia. Brain 1980; 103: 301-314.
7. Berardelli A, Sabra AF, Hallett M. Physiological mechanisms of rigidity in Parkinson's disease. J Neurol Neurosurg Psychiatry 1983; 46: 45-53.
8. Berardelli A, Rothwell JC, Thompson PD, Hallett M. Pathophysiology of bradykinesia in Parkinson's disease. Brain 2001; 124: 2131-2146.
9. Delwaide PJ, Pepin JL, De Pasqua V, de Noordhout AM. Projections from basal ganglia to tegmentum: a subcortical route for explaining the pathophysiology of Parkinson's disease signs? J Neurol 2000; 247( suppl 2): II75-II81.
10. Takakusaki K, Tomita N, Yano M. Substrates for normal gait and pathophysiology of gait disturbances with respect to the basal ganglia dysfunction. J Neurol 2008; 255( suppl 4): 19-29.
11. Blandini F, Nappi G, Tassorelli C, Martignoni E. Functional changes of the basal ganglia circuitry in Parkinson's disease. Prog Neurobiol 2000; 62: 63-88.
12. DeLong MR, Wichmann T. Circuits and circuit disorders of the basal ganglia. Arch Neurol 2007; 64: 20-24.
13. Braak H, Del Tredici K. Cortico-basal ganglia-cortical circuitry in Parkinson's disease reconsidered. Exp Neurol 2008; 212: 226-229.
14. Lewis GN, Byblow WD, Walt SE. Stride length regulation in Parkinson's disease: the use of extrinsic, visual cues. Brain 2000; 123(Pt 10): 2077-2090.
15. Pascual-Leone A, Valls-Sole J, Brasil-Neto JP, Cohen LG, Hallett M. Akinesia in Parkinson's disease. I. Shortening of simple reaction time with focal, single-pulse transcranial magnetic stimulation. Neurology 1994; 44: 884-891.
16. Chen R, Kumar S, Garg RR, Lang AE. Impairment of motor cortex activation and deactivation in Parkinson's disease. Clin Neurophysiol 2001; 112: 600-607.
17. Cantello R, Gianelli M, Bettucci D, Civardi C, De Angelis MS, Mutani R. Parkinson's disease rigidity: magnetic motor evoked potentials in a small hand muscle. Neurology 1991; 41: 1449-1456.
18. Lefaucheur JP. Motor cortex dysfunction revealed by cortical excitability studies in Parkinson's disease: influence of antiparkinsonian treatment and cortical stimulation. Clin Neurophysiol 2005; 116: 244-253.
19. Pierantozzi M, Palmieri MG, Marciani MG, Bernardi G, Giacomini P, Stanzione P. Effect of apomorphine on cortical inhibition in Parkinson's disease patients: a transcranial magnetic stimulation study. Exp Brain Res 2001; 141: 52-62.
20. Ellaway PH, Davey NJ, Maskill DW, Dick JP. The relation between bradykinesia and excitability of the motor cortex assessed using transcranial magnetic stimulation in normal and parkinsonian subjects. Electroencephalogr Clin Neurophysiol 1995; 97: 169-178.
21. Lou JS, Benice T, Kearns G, Sexton G, Nutt J. Levodopa normalizes exercise related cortico-motoneuron excitability abnormalities in Parkinson's disease. Clin Neurophysiol 2003; 114: 930-937.
22. Wu AD, Petzinger GM, Lin CH, Kung M, Fisher B. Asymmetric corticomotor excitability correlations in early Parkinson's disease. Mov Disord 2007; 22: 1587-1593.
23. Lefaucheur JP, Drouot X, Von Raison F, Menard-Lefaucheur I, Cesaro P, Nguyen JP. Improvement of motor performance and modulation of cortical excitability by repetitive transcranial magnetic stimulation of the motor cortex in Parkinson's disease. Clin Neurophysiol 2004; 115: 2530-2541.
24. Boonstra TA, van der Kooij H, Munneke M, Bloem BR. Gait disorders and balance disturbances in Parkinson's disease: clinical update and pathophysiology. Curr Opin Neurol 2008; 21: 461-471.
25. Taylor JL, Gandevia SC. Transcranial magnetic stimulation and human muscle fatigue. Muscle Nerve 2001; 24: 18-29.
26. Priori A, Bertolasi L, Dressler D, Rothwell JC, Day BL, Thompson PD, Marsden CD. Transcranial electric and magnetic stimulation of the leg area of the human motor cortex: single motor unit and surface EMG responses in the tibialis anterior muscle. Electroencephalogr Clin Neurophysiol 1993; 89: 131-137.
27. Rossini PM, Barker AT, Berardelli A, et al. Non-invasive electrical and magnetic stimulation of the brain, spinal cord and roots: basic principles and procedures for routine clinical application. Report of an IFCN committee. Electroencephalogr Clin Neurophysiol 1994; 91: 79-92.
28. Rothwell JC. Pathophysiology of the motor cortex in patients with Parkinson's disease. Adv Neurol 1999; 80: 27-29.
29. Garvey MA, Ziemann U, Becker DA, Barker CA, Bartko JJ. New graphical method to measure silent periods evoked by transcranial magnetic stimulation. Clin Neurophysiol 2001; 112: 1451-1460.
30. Ziemann U, Rothwell JC, Ridding MC. Interaction between intracortical inhibition and facilitation in human motor cortex. J Physiol 1996; 496(Pt 3): 873-881.
31. Eusebio A, Azulay JP, Witjas T, Rico A, Attarian S. Assessment of cortico-spinal tract impairment in multiple system atrophy using transcranial magnetic stimulation. Clin Neurophysiol 2007; 118: 815-823.
32. Ferrigno G, Pedotti A. ELITE: a digital dedicated hardware system for movement analysis via real-time TV signal processing. IEEE Trans Biomed Eng 1985; 32: 943-950.
33. Morris ME, Iansek R, Matyas TA, Summers JJ. Ability to modulate walking cadence remains intact in Parkinson's disease. J Neurol Neurosurg Psychiatry 1994; 57: 1532-1534.
34. Eusebio A, Azulay JP, Witjas T, Rico A, Attarian S. Assessment of cortico-spinal tract impairment in multiple system atrophy using transcranial magnetic stimulation. Clin Neurophysiol 2007; 118: 815-823.
35. Kuhn AA, Grosse P, Holtz K, Brown P, Meyer BU, Kupsch A. Patterns of abnormal motor cortex excitability in atypical parkinsonian syndromes. Clin Neurophysiol 2004; 115: 1786-1795.
36. Tremblay F, Tremblay LE. Cortico-motor excitability of the lower limb motor representation: a comparative study in Parkinson's disease and healthy controls. Clin Neurophysiol 2002; 113: 2006-2012.
37. Brouwer B, Ashby P. Corticospinal projections to lower limb motoneurons in man. Exp Brain Res 1992; 89: 649-654.
38. Capaday C, Lavoie BA, Barbeau H, Schneider C, Bonnard M. Studies on the corticospinal control of human walking. I. Responses to focal transcranial magnetic stimulation of the motor cortex. J Neurophysiol 1999; 81: 129-139.
39. Schubert M, Curt A, Jensen L, Dietz V. Corticospinal input in human gait: modulation of magnetically evoked motor responses. Exp Brain Res 1997; 115: 234-246.
40. Morris ME, Iansek R, Matyas TA, Summers JJ. Stride length regulation in Parkinson's disease. Normalization strategies and underlying mechanisms. Brain 1996; 119(Pt 2): 551-568.
41. Azulay JP, Mesure S, Amblard B, Blin O, Sangla I, Pouget J. Visual control of locomotion in Parkinson's disease. Brain 1999; 122(Pt 1): 111-120.
42. Hanakawa T, Fukuyama H, Katsumi Y, Honda M, Shibasaki H. Enhanced lateral premotor activity during paradoxical gait in Parkinson's disease. Ann Neurol 1999; 45: 329-336.
43. Cantello R, Tarletti R, Civardi C. Transcranial magnetic stimulation and Parkinson's disease. Brain Res Brain Res Rev 2002; 38: 309-327.
44. Martin RE, Goodyear BG, Gati JS, Menon RS. Cerebral cortical representation of automatic and volitional swallowing in humans. J Neurophysiol 2001; 85: 938-950.
45. Haouzi P, Chenuel B, Barroche G. Interactions between volitional and automatic breathing during respiratory apraxia. Respir Physiol Neurobiol 2006; 152: 169-175.
46. Miyai I, Tanabe HC, Sase I, et al. Cortical mapping of gait in humans: a near-infrared spectroscopic topography study. Neuroimage 2001; 14: 1186-1192.
47. Sahyoun C, Floyer-Lea A, Johansen-Berg H, Matthews PM. Towards an understanding of gait control: brain activation during the anticipation, preparation and execution of foot movements. Neuroimage 2004; 21: 568-575.
48. Luft AR, Smith GV, Forrester L, et al. Comparing brain activation associated with isolated upper and lower limb movement across corresponding joints. Hum Brain Mapp 2002; 17: 131-140.
49. Grafton ST, Hari R, Salenius S. The human motor system. In: Toga AW, Mazziotta JC, editors. Brain mapping: the systems. San Diego: Academic Press; 2000. p 331-363.
50. Passingham RE. Functional organization of the motor system. In: Frackowiak RS, Friston KJ, Frith CD, Dolan R, Mazziotta JC, editors. Human brain function. San Diego: Academic Press; 1997. p: 243-274.
51. Fukuyama H, Ouchi Y, Matsuzaki S, Hanakawa T, Nagahama Y, Shibasaki H. Brain functional activity during gait in Parkinson's disease. Mov Disord 1997;( suppl 1): 12.
52. Hanakawa T, Katsumi Y, Fukuyama H, Honda M, Hayashi T, Kimura J, Shibasaki H. Mechanisms underlying gait disturbance in Parkinson's disease: a single photon emission computed tomography study. Brain 1999; 122(Pt 7): 1271-1282.
53. Vidailhet M, Stocchi F, Rothwell JC, Thompson PD, Day BL, Brooks DJ, Marsden CD. The Bereitschaftspotential preceding simple foot movement and initiation of gait in Parkinson's disease. Neurology 1993; 43: 1784-1788.
54. Mito Y, Yoshida K, Yabe I, Makino K, Tashiro K, Kikuchi S, Sasaki H. Brain SPECT analysis by 3D-SSP and clinical features of Parkinson's disease. Hokkaido Igaku Zasshi 2006; 81: 15-23.
55. Baumer T, Hidding U, Hamel W, et al. Effects of DBS, premotor rTMS, and levodopa on motor function and silent period in advanced Parkinson's disease. Mov Disord 2009; 24: 672-676.
56. Fitzgerald PB, Fountain S, Daskalakis ZJ. A comprehensive review of the effects of rTMS on motor cortical excitability and inhibition. Clin Neurophysiol 2006; 117: 2584-2596.
57. Fregni F, Simon DK, Wu A, Pascual-Leone A. Non-invasive brain stimulation for Parkinson's disease: a systematic review and meta-analysis of the literature. J Neurol Neurosurg Psychiatry 2005; 76: 1614-1623.
58. Elahi B, Elahi B, Chen R. Effect of transcranial magnetic stimulation on Parkinson motor function--systematic review of controlled clinical trials. Mov Disord 2009; 24: 357-363.
59. Hamada M, Ugawa Y, Tsuji S. High-frequency rTMS over the supplementary motor area for treatment of Parkinson's disease. Mov Disord 2008; 23: 1524-1531.
60. Hamada M, Ugawa Y, Tsuji S. High-frequency rTMS over the supplementary motor area improves bradykinesia in Parkinson's disease: subanalysis of double-blind sham-controlled study. J Neurol Sci 2009; 287: 143-146.
61. Khedr EM, Rothwell JC, Shawky OA, Ahmed MA, Hamdy A. Effect of daily repetitive transcranial magnetic stimulation on motor performance in Parkinson's disease. Mov Disord 2006; 21: 2201-2205.
62. Lomarev MP, Kanchana S, Bara-Jimenez W, Iyer M, Wassermann EM, Hallett M. Placebo-controlled study of rTMS for the treatment of Parkinson's disease. Mov Disord 2006; 21: 325-331.